145 related articles for article (PubMed ID: 33555783)
1. Assessing the Feasibility of an Alternative Payment Model for Mohs Micrographic Surgery at an Academic Center.
Auh S; Chitgopeker P; Hammel J; Ferguson N; Johnson-Jahangir H; Van Beek M
Dermatol Surg; 2020 Jun; 46(6):735-741. PubMed ID: 33555783
[TBL] [Abstract][Full Text] [Related]
2. A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption.
Rogers HW; Coldiron BM
J Am Acad Dermatol; 2009 Jul; 61(1):96-103. PubMed ID: 19539843
[TBL] [Abstract][Full Text] [Related]
3. Mohs micrographic surgery: a cost analysis.
Cook J; Zitelli JA
J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):698-703. PubMed ID: 9810885
[TBL] [Abstract][Full Text] [Related]
4. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up.
Mosterd K; Krekels GA; Nieman FH; Ostertag JU; Essers BA; Dirksen CD; Steijlen PM; Vermeulen A; Neumann H; Kelleners-Smeets NW
Lancet Oncol; 2008 Dec; 9(12):1149-56. PubMed ID: 19010733
[TBL] [Abstract][Full Text] [Related]
5. [Complete treatment of basal cell carcinoma; cost effectiveness of Mohs micrographic surgery versus conventional excision].
Muche JM; van Rengen A; Mosterd K
Ned Tijdschr Geneeskd; 2017; 161():D1549. PubMed ID: 29303086
[TBL] [Abstract][Full Text] [Related]
6. Mohs Micrographic Surgery Volume and Payment Patterns Among Dermatologists in the Medicare Population, 2013.
Johnstone C; Joiner KA; Pierce J; Krouse RS
Am J Clin Oncol; 2018 Dec; 41(12):1199-1203. PubMed ID: 29672366
[TBL] [Abstract][Full Text] [Related]
7. Cost effectiveness of Mohs micrographic surgery: review of the literature.
Tierney EP; Hanke CW
J Drugs Dermatol; 2009 Oct; 8(10):914-22. PubMed ID: 19852120
[TBL] [Abstract][Full Text] [Related]
8. Mohs micrographic surgery for melanoma: A prospective multicenter study.
Ellison PM; Zitelli JA; Brodland DG
J Am Acad Dermatol; 2019 Sep; 81(3):767-774. PubMed ID: 31150700
[TBL] [Abstract][Full Text] [Related]
9. Cost analysis: Mohs micrographic surgery.
Ravitskiy L; Brodland DG; Zitelli JA
Dermatol Surg; 2012 Apr; 38(4):585-94. PubMed ID: 22443180
[TBL] [Abstract][Full Text] [Related]
10. Quantity and characteristics of flap or graft repairs for skin cancer on the nose or ears: a comparison between Mohs micrographic surgery and plastic surgery.
Hill D; Kim K; Mansouri B; Sager L; Housewright C
Cutis; 2019 May; 103(5):284-287. PubMed ID: 31233572
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of Melanoma In Situ Treated With Mohs Micrographic Surgery Compared With Wide Local Excision.
Nosrati A; Berliner JG; Goel S; McGuire J; Morhenn V; de Souza JR; Yeniay Y; Singh R; Lee K; Nakamura M; Wu RR; Griffin A; Grimes B; Linos E; Chren MM; Grekin R; Wei ML
JAMA Dermatol; 2017 May; 153(5):436-441. PubMed ID: 28241261
[TBL] [Abstract][Full Text] [Related]
12. Analysis of skin cancer treatment and costs in the United States Medicare population, 1996-2008.
Rogers HW; Coldiron BM
Dermatol Surg; 2013 Jan; 39(1 Pt 1):35-42. PubMed ID: 23199014
[TBL] [Abstract][Full Text] [Related]
13. Association of Tumor Characteristics With Insurance Type Among Patients Undergoing Mohs Micrographic Surgery for Nonmelanoma Skin Cancer.
Clarke EL; Willenbrink TJ; Shelton M; Naeem A; Custer J; Lundgren AD; Boothe WD; Rathouz PJ; Adamson AS; Fox MC; Jambusaria-Pahlajani A
JAMA Dermatol; 2022 Aug; 158(8):919-922. PubMed ID: 35648411
[TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness of intermediate-risk squamous cell carcinoma treated with Mohs micrographic surgery compared with wide local excision.
Udkoff J; Beal BT; Brodland DG; Knackstedt T
J Am Acad Dermatol; 2022 Feb; 86(2):303-311. PubMed ID: 34363906
[TBL] [Abstract][Full Text] [Related]
15. A comparison between Mohs micrographic surgery and wide surgical excision for the treatment of dermatofibrosarcoma protuberans.
Gloster HM; Harris KR; Roenigk RK
J Am Acad Dermatol; 1996 Jul; 35(1):82-7. PubMed ID: 8682970
[TBL] [Abstract][Full Text] [Related]
16. Mohs micrographic surgery and surgical excision for nonmelanoma skin cancer treatment in the Medicare population.
Viola KV; Jhaveri MB; Soulos PR; Turner RB; Tolpinrud WL; Doshi D; Gross CP
Arch Dermatol; 2012 Apr; 148(4):473-7. PubMed ID: 22508870
[TBL] [Abstract][Full Text] [Related]
17. An ecological study of skin biopsies and skin cancer treatment procedures in the United States Medicare population, 2000 to 2015.
Wang DM; Morgan FC; Besaw RJ; Schmults CD
J Am Acad Dermatol; 2018 Jan; 78(1):47-53. PubMed ID: 28947293
[TBL] [Abstract][Full Text] [Related]
18. Preoperative Patient Profile in Total Hip and Knee Arthroplasty: Predictive of Increased Medicare Payments in a Bundled Payment Model.
Karas V; Kildow BJ; Baumgartner BT; Green CL; Attarian DE; Bolognesi MP; Seyler TM
J Arthroplasty; 2018 Sep; 33(9):2728-2733.e3. PubMed ID: 29793850
[TBL] [Abstract][Full Text] [Related]
19. MMS hotspots: a cross-sectional comparison of U.S. counties with and without Mohs micrographic surgery.
Sharma AN; Peterman N; Juhasz M; Shive M
Arch Dermatol Res; 2023 Dec; 316(1):21. PubMed ID: 38060044
[TBL] [Abstract][Full Text] [Related]
20. Mohs micrographic surgery vs traditional surgical excision: a cost comparison analysis.
Bialy TL; Whalen J; Veledar E; Lafreniere D; Spiro J; Chartier T; Chen SC
Arch Dermatol; 2004 Jun; 140(6):736-42. PubMed ID: 15210467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
